ATE411993T1 - Muscarine agonisten als therapeutische verbindungen - Google Patents
Muscarine agonisten als therapeutische verbindungenInfo
- Publication number
- ATE411993T1 ATE411993T1 AT04805924T AT04805924T ATE411993T1 AT E411993 T1 ATE411993 T1 AT E411993T1 AT 04805924 T AT04805924 T AT 04805924T AT 04805924 T AT04805924 T AT 04805924T AT E411993 T1 ATE411993 T1 AT E411993T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic compounds
- agonists
- muscarine
- muscarine agonists
- stimulating
- Prior art date
Links
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 239000000472 muscarinic agonist Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0328295.1A GB0328295D0 (en) | 2003-12-05 | 2003-12-05 | Therapeutic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE411993T1 true ATE411993T1 (de) | 2008-11-15 |
Family
ID=29764691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04805924T ATE411993T1 (de) | 2003-12-05 | 2004-12-06 | Muscarine agonisten als therapeutische verbindungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7691857B2 (de) |
| EP (1) | EP1697359B1 (de) |
| JP (1) | JP2007513136A (de) |
| AT (1) | ATE411993T1 (de) |
| DE (1) | DE602004017354D1 (de) |
| GB (1) | GB0328295D0 (de) |
| WO (1) | WO2005054242A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8314391D0 (en) * | 1983-05-24 | 1983-06-29 | Kefalas As | Heterocyclic compounds |
| EP0515535A4 (en) * | 1990-02-13 | 1996-01-17 | Merck & Co Inc | Angiotensin ii antagonists incorporating a substituted benzyl element |
| FR2663929A1 (fr) * | 1990-06-29 | 1992-01-03 | Adir | Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| AU5919001A (en) * | 2000-04-28 | 2001-11-12 | Acadia Pharm Inc | Muscarinic agonists |
-
2003
- 2003-12-05 GB GBGB0328295.1A patent/GB0328295D0/en not_active Ceased
-
2004
- 2004-12-06 EP EP04805924A patent/EP1697359B1/de not_active Expired - Lifetime
- 2004-12-06 WO PCT/GB2004/005096 patent/WO2005054242A1/en not_active Ceased
- 2004-12-06 AT AT04805924T patent/ATE411993T1/de not_active IP Right Cessation
- 2004-12-06 DE DE602004017354T patent/DE602004017354D1/de not_active Expired - Lifetime
- 2004-12-06 JP JP2006542022A patent/JP2007513136A/ja active Pending
- 2004-12-06 US US10/581,833 patent/US7691857B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1697359A1 (de) | 2006-09-06 |
| DE602004017354D1 (de) | 2008-12-04 |
| WO2005054242A1 (en) | 2005-06-16 |
| GB0328295D0 (en) | 2004-01-07 |
| US7691857B2 (en) | 2010-04-06 |
| JP2007513136A (ja) | 2007-05-24 |
| US20080039469A1 (en) | 2008-02-14 |
| EP1697359B1 (de) | 2008-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA87153C2 (ru) | Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| NI200600094A (es) | Compuesto heterociclicos fusionados | |
| DK1379246T3 (da) | Nocieptin-analoger | |
| EA200301215A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
| CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
| EA200701114A1 (ru) | Азоловые производные с антимускариновой активностью | |
| ATE384061T1 (de) | Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren | |
| EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
| NO20062950L (no) | 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet | |
| DE60314623D1 (de) | Substituierte pyrazolopyrimidine | |
| ATE490253T1 (de) | Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen | |
| MX2007003108A (es) | Compuestos imidazo-3-il-amina sustituidos y biciclicos. | |
| NO20060230L (no) | Nye aminobenzofenonforbindelser | |
| ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
| ATE384039T1 (de) | Indanderivate als muscarinrezeptoragonisten | |
| UY28333A1 (es) | Inhibidores de caspasa y sus usos. | |
| CL2007002899A1 (es) | Compuestos derivados de azaciclilaminas n-sustituidas, inhibidores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica que comprende los compuestos, y usopara el tratamiento de trastornos cognitivos, esquizofre nia y enfermedad de alzheimer entre otros. | |
| ATE438398T1 (de) | Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren | |
| EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
| BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
| ATE375978T1 (de) | Benzoylsulfonamide als antitumor-mittel | |
| UY29197A1 (es) | Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos | |
| ATE370955T1 (de) | N-sulfonylheterocyclopyrrolylalkylamin verbindungen als 5-hydroxytryptamin-6 liganden. | |
| ATE387449T1 (de) | Pyrazolopyrimidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |